About Aphria
Aphria is a company based in Leamington (Canada) founded in 2014 by Cole Cacciavillani. Aphria has completed 3 acquisitions, including Broken Coast, CC Pharma and Nuuvera. Aphria operates in a competitive market with competitors including iAnthus, PharmHouse, CannaVcell, Bloomera and CannaVerde Pharma, among others.
- Headquarter Leamington, Canada
- Founders Cole Cacciavillani
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$300 M (USD), Post-IPO
Apr 23, 2019
-
Investors
Flow Capital
& 4 more
-
Employee Count
Not available
-
Investments & Acquisitions
Broken Coast
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Aphria
Unlock access to complete
Unlock access to complete
Software Development Team
32 people
Leadership Team
19 people
Legal and Compliance
8 people
Data Analysis and Operations Team
7 people
Human Resources and Administration
6 people
Sales and Marketing
6 people
Product Management Team
5 people
Senior Team
5 people
Unlock access to complete
Funding Insights of Aphria
Investors in Aphria
Aphria has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Flow Capital, WFCU Credit Union and Delavaco Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Delavaco Group is engaged in private equity and corporate restructuring.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Provider of venture debt and revenue-based financing solutions tailored for businesses
|
Locked | Locked | Locked |
Investor details for Aphria
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aphria
Aphria has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Broken Coast, CC Pharma and Nuuvera.
Investment portfolio details for Aphria
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabis-based medicinal products are produced and distributed by Nuuvera.
|
Locked | Locked | 2017 | Locked | |
|
Cannabis is cultivated and processed hydroponically by Broken Coast.
|
Locked | Locked | 2014 | Locked | |
|
Pharmaceutical products are distributed by CC Pharma in Germany.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Aphria
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Aphria
Detailed financials for Aphria
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aphria Comparisons
Peer comparison for Aphria
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aphria
Aphria operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iAnthus, PharmHouse, CannaVcell, Bloomera and CannaVerde Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cannabis products are cultivated and processed for medical use.
|
|
| Locked | Locked | Locked |
Develops innovative technologies for greenhouse cannabis cultivation facilities.
|
|
| Locked | Locked | Locked |
Provides patented technology for bio-harvesting cannabis.
|
|
| Locked | Locked | Locked |
Cultivator and producer of cannabis products
|
|
| Locked | Locked | Locked |
Cannabis varieties are cultivated and manufactured for research and pharmaceuticals.
|
Detailed competitors of Aphria
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aphria
Complete news archive for Aphria
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aphria
Aphria was founded in 2014.
Aphria is headquartered in Leamington, Canada. It is registered at Leamington, Ontario, Canada.
Aphria was founded in 2014 in Leamington, Canada, as a provider in the cannabis sector. A range of products, including CBD oil, tinctures, gel capsules, pre-rolls, cartridges, flowers, and topicals, is offered. These items are used to address pain, anxiety, sleep disorders, PTSD, and addiction. Operations focus on nutritional and wellness applications within the Canadian market.
Aphria's top competitors include iAnthus, Bloomera and CannaVerde Pharma.
Aphria has made 3 acquisitions, including Broken Coast, CC Pharma, and Nuuvera.
Aphria has 5 investors. Key investors include Flow Capital, WFCU Credit Union, Delavaco Group, York Plains Investment, and Broadband Capital Partners.